True North Therapeutics
Founded Year
2013Stage
Acquired | AcquiredTotal Raised
$142MValuation
$0000About True North Therapeutics
True North Therapeutics is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases. The company's lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway. True North's antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system.
True North Therapeutics Headquarter Location
951 Gateway Blvd
South San Francisco, California, 94080,
United States
650-872-4700
Expert Collections containing True North Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
True North Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
838 items
True North Therapeutics Patents
True North Therapeutics has filed 11 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/20/2016 | 10/29/2019 | Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors | Grant |
Application Date | 12/20/2016 |
|---|---|
Grant Date | 10/29/2019 |
Title | |
Related Topics | Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors |
Status | Grant |
Latest True North Therapeutics News
Mar 16, 2020
The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group . All rights reserved. All other trademarks recognized. Copyright © 2020 ND2A Group. Site developed by Alacrify Ltd .
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.